Trials / Sponsors / Changzhou Qianhong Bio-pharma Co., Ltd.
Changzhou Qianhong Bio-pharma Co., Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. Acute Ischemic Stroke | Phase 2 | 2026-01-19 |
| Recruiting | Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) | Phase 2 | 2023-08-10 |
| Completed | Study to Assess PK, Safety and Tolerability in Healthy Subjects Acute Ischemic Stroke | Phase 1 | 2023-03-16 |
| Completed | Study to Assess PK, Safety and Tolerability Early in Healthy Subjects Acute Ischemic Stroke | Phase 1 | 2021-07-05 |